Biogen Inc
BMV:BIIB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biogen Inc
BMV:BIIB
|
US |
|
S
|
Sasol Ltd
XMUN:SAOA
|
ZA |
|
Stellantis NV
F:8TI
|
NL |
|
P
|
Pitney Bowes Inc
F:PBW
|
US |
|
N
|
Nintendo Co Ltd
DUS:NTO
|
JP |
|
B
|
Biogen Inc
XHAM:IDP
|
US |
|
Masco Corp
NYSE:MAS
|
US |
|
C
|
Computacenter PLC
SWB:COUD
|
UK |
|
D
|
Dollar Tree Inc
F:DT3
|
US |
|
RTL Group SA
XETRA:RRTL
|
LU |
|
F
|
Franklin Resources Inc
BMV:BEN
|
US |
|
I
|
Ispire Technology Inc
NASDAQ:ISPR
|
US |
|
A
|
Accenture PLC
SWB:CSA
|
IE |
|
A
|
Advanced Micro Devices Inc
MIL:1AMD
|
US |
|
Schibsted ASA
OSE:SCHB
|
NO |
|
U
|
United Natural Foods Inc
F:UN3
|
US |
|
S
|
Schumag AG
XHAM:SCM
|
DE |
|
C
|
China Citic Bank Corp Ltd
SWB:D7C
|
CN |
|
C
|
Carnival Corp
F:CVC1
|
US |
|
J
|
JPMorgan Chase & Co
SWB:CMC
|
US |
|
Blend Labs Inc
NYSE:BLND
|
US |
|
C
|
Compass Inc
F:91D
|
US |
|
M
|
Marathon Petroleum Corp
F:MPN
|
US |
|
Chunghwa Telecom Co Ltd
TWSE:2412
|
TW |
Bankruptcy Probability
Biogen Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Biogen Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Biogen Inc
NASDAQ:BIIB
|
27.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
375.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
179B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
68.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Biogen Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Biogen Inc has total debt of 6.3B USD. This includes both short-term (0 USD) and long-term (6.3B USD) debt.
You can find a full breakdown on its Balance Sheet.
